Yes. TauroPace™ has been certified for adjunct use during any CIED procedure and on any uncoated or silicon-, epoxy- or polyurethane-coated CIED (including its components, e.g. leads) made of titan or stainless steel. The certification includes reviewing safety data and biocompatibility.
No. TauroPace™ has been designed specifically for CIEDs. It has been tested on uncoated or silicon-, epoxy- or polyurethane-coated CIEDs (including components, e.g. leads) made of titan or stainless steel.
No. There have not been any reports about AE or severe AE for the adjunct use of TauroPace™ for its intended purposes.
No. There have not been any reports about AE or severe AE for the adjunct use of TauroPace™ for its intended purposes.
There are no side effects that have been reported for after use of TauroPace™ with CIEDs.
We do not recommend the simultaneous use of TauroPace™ and other substances or devices on the CIED and its components. Please use TauroPace™ only on the CIED. Before the incision and after closing the wound, we recommend using your preferred antiseptic agent.
Although TYRX™ and TauroPace™ are unlikely to interfere with each other, we do not recommend using both simultaneously. There are no data supporting simultaneous use.
Do not use PVP iodine. It contains ethanol, which enhances biofilm formation in the presence of Staph. aureus colony forming units. Simultaneous use of PVP iodine and TauroPace™ might result in the formation of an acid. Please use TauroPace™ only on the CIED before final placement.
CanGaroo® and TauroPace™ can be used simultaneously.
Using TauroPace™ and hydrogen peroxide simultaneously is strongly discouraged.
TauroPace™ is an antimicrobial solution designed to prevent contamination of cardiac implantable electronic devices (CIED) such as pacemakers or implantable cardioverter defibrillators.
TauroPace™ contains taurolidine as an ancillary active substance.
TauroPace™ may prevent the CIED from being contaminated before final placement.
There are no known side effects caused by the use of TauroPace™.
TauroPace™ is designed for maintenance of sterility before implantation. Although no safety issues are to be expected from unintended exposure, any TauroPace™ thereby coming into contact with the implantation site (e.g. by rinsing) needs to be removed before suture.
TauroPace™ does not interfere with the functions of a CIED.
TauroPace™ interferes with different antimicrobial substances such as polyhexanide, octenidine, hydrogen-peroxide, or hypochlorous acid. Therefore, we do not recommend using TauroPace™ and other antimicrobial substances simultaneously.
TauroPace™ can be used during any surgery before final placement (i.e. surgical procedures of implantation, lead implantation, or extraction, with the aim of up- or downgrading, revision, or generator substitution).
You can always ask your attending physician if it is possible to use TauroPace™ in your case.
Staff coughing, sneezing, and shedding from clothing can contribute to airborne contamination. In this regard, traffic during surgery can also disrupt airflow and introduce microbes. Contact of the implant with the patient's skin might introduce bacteria to the CIED surface.